CD8A and chronic kidney disease: Following the first and second vaccine dose IFNy producing spike-specific CD8+ T-cells were detected in 50 % (10/20) respectively 90 % (18/20) in patients with CKD and in 78 % (7/9) respectively 100 % (9/9) of controls.